Latest Lead News

SPC Global reports stronger-than-expected FY25 results driven by international growth and synergy gains, while unveiling a new premium beverage division and a major lender transition.

Viva Energy's half-year results reveal a resilient Commercial segment offsetting pressures in Refining and Retail, as the company advances its retail transformation and cost synergy targets.

Johns Lyng Group reported a modest revenue increase to $1.18 billion in FY25, driven by organic growth and key acquisitions, while agreeing to a $1.1 billion takeover scheme with Pacific Equity Partners.

Aurelia Metals delivered a robust FY25 with a $48.9 million net profit and strong operational execution, advancing key projects like Federation and Great Cobar while maintaining a solid balance sheet.

Aurelia Metals Limited has reported a strong turnaround with a $48.9 million net profit for FY25, driven by operational progress at its Federation Mine and the approval of the Great Cobar Project. The company’s strategic focus on base metals growth and sustainability underpins its improved financial and safety performance.

Felix Group Holdings Ltd has launched a capped $1 million Share Purchase Plan (SPP) offering eligible shareholders a discounted entry to support its strategic acquisition of Nexvia Pty Ltd and fuel growth initiatives. This retail-focused SPP complements a larger institutional placement as Felix aims to expand its enterprise software footprint.

Mammoth Minerals has initiated the second phase of exploration at its Excelsior Gold-Silver Project in Nevada, leveraging a pioneering 3D underground survey of the historic Blue Dick Mine to guide upcoming drilling.

G8 Education reported a 3.7% revenue decline but a 12.4% rise in net profit for the first half of 2025, amid ongoing cost-of-living challenges impacting occupancy. The company declared a dividend and announced a share buyback, underscoring confidence despite sector headwinds.

G8 Education Limited reported a moderate earnings improvement for the half year ended June 2025 despite ongoing occupancy challenges and regulatory uncertainty. The company is intensifying child safety measures following a Victorian incident and plans a share buy-back to enhance shareholder value.

Australian Clinical Labs delivered solid FY25 financial results with revenue up 6.4% and EBIT rising 8.7%, underpinned by operational efficiencies and strategic innovation. The company’s FY26 guidance signals continued growth amid evolving market conditions and government fee pressures.

Australian Clinical Labs reported robust FY25 financial results with revenue and earnings growth, alongside a strong dividend payout and positive outlook for FY26.

Australian Clinical Labs reported a 6.4% revenue increase and an 8.7% rise in underlying EBIT for FY25, maintaining disciplined growth and operational efficiency in a complex healthcare environment.